The GSTM1 null genotype was also associated with elevated risk of bladder cancer stratified by smoking status (OR 1.37, 95%CI: 1.19-1.59 for smokers and OR 1.26, 95%CI: 1.08-1.48 for non-smokers, respectively). Here, GSTM1 is linked to urinary bladder carcinoma.